Public Offering

Sidus Space (SIDU) announced a public offering of 9.8 million Class A common shares at $1.00 per share, expecting gross proceeds of $9.8 million. The offering is set to close on September 16, 2025, with ThinkEquity as the sole placement agent. Net proceeds will go towards working capital and general corporate expenses. This capital raise aims to support Sidus Space’s operations and strategic investments amid rising competition in the space technology sector. The offering is based on a shelf registration statement filed with the SEC.

AIRO Group Holdings, Inc. (NASDAQ: AIRO) announced the pricing of its upsized underwritten public offering of 4,200,000 shares at $18.50 per share, expected to generate $77.7 million in gross proceeds. Underwriters have an option to purchase additional shares. Proceeds will fund strategic growth, potential acquisitions, and repurchase shares from select stockholders. Cantor is the lead book-running manager. AIRO focuses on aerospace, autonomy, and air mobility, targeting drones, avionics, training, and electric air mobility. The registration statement for the offering was declared effective by the SEC on September 10, 2025.

Rapport Therapeutics (RAPP) announced the pricing of its public offering of 9,615,385 shares at $26.00 per share, potentially generating $250 million in gross proceeds. Underwriters have a 30-day option to purchase an additional 1,442,307 shares. The offering, managed by Goldman Sachs, Jefferies, TD Cowen, and Stifel, is expected to close around September 11, 2025. Funds will support the clinical-stage biotech’s work on neurological and psychiatric disorders.

On September 3, 2025, Customers Bancorp (CUBI) announced the pricing of a public offering of 2,189,781 shares of voting common stock at $68.50 per share, expected to generate $150 million. Underwriters have an option to purchase additional shares. Net proceeds will be used for general corporate purposes, including organic growth, debt refinancing, share repurchases, preferred stock redemption, capital investments, and potential acquisitions. The offering is expected to close around September 5, 2025. This move strengthens the bank’s balance sheet amid a complex economic environment.

AGNC Investment Corp. (Nasdaq: AGNC) announced the pricing of a public offering of 12,000,000 depositary shares representing preferred stock, with gross proceeds of $300 million. Underwriters have a 30-day option for additional shares. Listing on Nasdaq is planned under “AGNCZ,” with closing expected around September 10, 2025. Proceeds will be invested in a diversified portfolio including Agency securities and credit risk transfer securities. Managed by a consortium of financial institutions, the offering is under an existing shelf registration statement. The strategy aims to bolster capital amid volatile market conditions.

Thumzup Media (TZUP) updated its public offering to include pre-funded warrants for common stock. The funds will target cryptocurrencies, mining equipment, working capital, and general corporate purposes. The offering’s completion is subject to market conditions. Thumzup’s platform pays users for sharing branded content and is developing an AI Lifestyle Agent Marketplace. The announcement contains forward-looking statements subject to risks. Investors should carefully review SEC filings and the prospectus before investing.

Southwest Gas Holdings is reducing its stake in Centuri Holdings through a secondary public offering of 15 million shares at $19.50 each. Underwriters have an option to purchase an additional 2.25 million shares. Carl Icahn’s affiliates will acquire 1,573,500 shares in a concurrent private placement at the same price. J.P. Morgan, Wells Fargo Securities, BofA Securities, and Moelis & Company are lead book-running managers. The offering, expected to close on August 11th, marks Southwest Gas’s strategic realignment and could signal further changes in its Centuri investment.

Prime Medicine (PRME) announced a public offering of 38 million shares at $3.30 per share, expecting $125.4 million in gross proceeds. The Cystic Fibrosis Foundation will purchase 1.8 million shares without underwriter commissions. Underwriters have an option to purchase 5.7 million additional shares. The offering, managed by TD Cowen and BMO Capital Markets, is set to close around August 1, 2025. Proceeds will bolster Prime Medicine’s gene therapy pipeline advancement. The offering may cause dilution for existing shareholders.

SoFi Technologies (NASDAQ: SOFI) has priced its public offering of 71,942,450 shares at $20.85 per share, generating approximately $1.5 billion in gross proceeds. Underwriters have a 30-day option to purchase an additional 10,791,367 shares. The offering is expected to close on July 31, 2025, and SoFi intends to use the proceeds for general corporate purposes, including working capital and strategic opportunities. Goldman Sachs, Citigroup, and Mizuho Securities are acting as underwriters. SoFi offers a suite of digital financial services to over 11.7 million members.

Absci (ABSI) announced the pricing of its public offering of 16,670,000 shares at $3.00 per share, expecting gross proceeds of $50 million. Underwriters have a 30-day option to purchase an additional 2,500,500 shares. Absci will use the funds for program advancements, platform investment, and general corporate purposes. Morgan Stanley, J.P. Morgan, Jefferies, and TD Cowen are managing the offering, expected to close around July 25, 2025.